LBA67 Phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients (Pts) with renal cell carcinoma (RCC) undergoing nephrectomy (PROSPER, ECOG-ACRIN EA8143), a National Clinical Trials Network trial
Authors:
- M. AllafMAM. Allaf
- S.E. KimSKS.E. Kim
- L.C. HarshmanLHL.C. Harshman
- D.F. McDermottDMD.F. McDermott
- V.A. MasterVMV.A. Master
- S. SignorettiSSS. Signoretti
- S. ColeSCS. Cole
- H. MoonHMH. Moon
- N. AdraNAN. Adra
- E.A. SingerESE.A. Singer
- J. GillsJGJ. Gills
- T.K. ChoueiriTCT.K. Choueiri
- 13 September 2022
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 33 (7) , S1432-S1433